Fibromyalgia syndrome and depression: Common pathways

British Journal of Hospital Medicine

Volumn 73, Issue 4, 2012, Pages 211-217

  Dunne, Francis J ^a   Dunne, Ciaran A ^b  

^a NORTH EAST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860571014     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2012.73.4.211     Document Type: Review

References (47)

1. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK (2005) Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 9:463-84 (Pubitemid 40836040)
2. Arnold LM (2006) Review: new therapies in fibromyalgia. Arthritis Res 8:212
3. Arnold LM, Goldenberg DL, Stanford SB et al (2007) Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum 56(4):1336-44 (Pubitemid 46608659)
4. Bair MJ, Robinson RL, Katon W, Konekes K (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163:2433-45 (Pubitemid 37385786)
5. Barrett KE, Barman SM, Boitano S, Brooks HL (2010) Ganong's Review of Medical Physiology. 23rd edn. McGraw Hill, New York
6. Bennett R (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23:154-62
7. Boomershine CS, Birol E, Yi Wang MS, Zlateva G (2011) Simplifying Fibromyalgia Assessment. The VASFIQ Brief Symptom Scale. Ther Adv Musculoskel Dis 3(5):215-26
8. Bradley A, McKendree-Smith NL, Alberts KR, Alarcón GS, Mountz JM, Deutsch G (2000) Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia. Curr Rheum Res 2:141-8
9. Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire (FIQ): development and validation. J Rheumatol 18:728-33
10. Calandre E P, Vilchez JS, Molina-Barea R et al (2011) Suicide attempts and risk of suicide in patients with fibromyalgia: a survey in Spanish patients. Rheumatology 50:1889-93
11. Carville S F, Arendt-Nielsen S, Bliddal H et al (2008) EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67:536-41 (Pubitemid 351498437)
12. Clauw DJ, Arnold LM, McCarberg BH (2011) The science of fibromyalgia. Mayo Clin Proc 86:907-11
13. Cook DB, Stegner AJ, McLoughlin MJ (2007) Imaging pain from fibromyalgia. Curr Pain Headache Rep 11:190-200
14. Doherty M, Jones A (1995) Fibromyalgia syndrome. BMJ 310:386-9
15. Dunne FJ (2011) Depression and pain. Is there a common pathway? British Journal of Medical Practitioners 4(1):a411 (www.bjmp.org/content/depression-and- pain-there-common-pathway accessed 20 March 2012)
16. Dunne FJ, Dunne CA (1995) Fibromyalgia syndrome and psychiatric disorder. Br J Hosp Med 54(5):194-7
17. Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM (2004) The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? J Clin Psychiatry 65:521-30
18. Fitzcharles MA, Costa DD, Poyhia R (2003) A study of standard care in fibromyalgia syndrome: a favorable outcome. J Rheumatol 30:154-9 (Pubitemid 36077788)
19. Goldenberg DL (2009) Diagnosis and differential diagnosis of fibromyalgia. Am J Med 122(supp):14-21
20. Gracely RH, Ambrose KR (2011) Neuroimaging of fibromyalgia. Best Pract Res Clin Rheum 25:271-84
21. Gracely RH, Petzke F, Wolf JM, Clauw DJ (2002) Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46:1333-43 (Pubitemid 34525843)
22. Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK (2007) Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 27:10000-6 (Pubitemid 47404015)
23. Harris RE, Sundgren PC, Craig AD, Kirshenbaum E, Sen A, Napadow V, Clauw DJ (2009) Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 10:3146-52
24. Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L (1992) Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92:363-7
25. Jaschko G, Hepp U, Berkhoff M et al (2007) Serum serotonin levels are not useful in diagnosing fibromyalgia. Ann Rheum Dis 66:1267-8 (Pubitemid 47315536)
26. Kennelly PJ, Rodwell VW (2006) Bioinformatics & computational biology. In: Murray RK, Granner DK, Rodwell VW, eds. Harper's Illustrated Biochemistry. 27th edn. McGraw Hill, New York: 82-7
27. Kuchinad A, Schweinhardt P, Seminowicz DA, Wood PB, Chizh BA, Bushnell MC (2007) Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain. J Neurosci 27:4004-7 (Pubitemid 46597143)
28. Langford CA, Gilliland BC (2008) Fibromyalgia. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL. Loscalzo J, eds. Harrison's Principles of Internal Medicine. 17th edn. McGraw Hill Medical, New York: 2175-7
29. Lee YC, Nassikas NJ, Clauw DJ (2011) The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia. Arthritis Res Ther 13:211
30. Mountz JM, Bradley LA, Modell JG et al (1995) Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 38:926-38
31. Nampiaparampil DE, Schmerling RH (2004) A review of fibromyalgia. Am J Manag Care 10:794-800 (Pubitemid 39518524)
32. Nihalani ND, Schwartz T, Chlebowski S (2006) Fibromyalgia-A review for the psychiatrist. Psychiatry 3:44-60
33. Nishishinya B, Urrutia G, Walitt B et al (2008) Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology 47:1741-6
34. Price DD, Staud R (2005) Neurobiology of fibromyalgia syndrome. J Rheumatol 75(Suppl):22-9
35. Roskell NS, Beard SM, Yang Z, Kim Le T (2011) A meta-analysis of pain response in the treatment of fibromyalgia. Pain Practice 11:516-17
36. Russell IJ (1999) Is fibromyalgia a distinct clinical entity? The clinical investigator's evidence. Best Pract Res Clin Rheumatol 13:445-54 (Pubitemid 30052719)
37. Russell IJ (2002) The promise of substance P inhibitors in fibromyalgia. Rheum Dis Clin North Am 28:329-42 (Pubitemid 34733187)
38. Russell IJ, Orr MD, Littman B et al (1994) Elevated cerebrospinal levels of substance p in patients with the fibromyalgia syndrome. Arthritis Rheum 37:1593-601 (Pubitemid 24345805)
39. Russell IJ, Alarcón GS, Bradley LA (1998) Advances in fibromyalgia: possible role for central neurochemicals. Am J Med Sci 315:377-84 (Pubitemid 28285132)
40. Walitt B, Fitzcharles MA, Hassett AF, Katz RS, Hauser W, Wolfe F (2011) The longitudinal outcome of fibromyalgia: a study of 1555 patients. J Rheumatol 38:2238-46
41. Williams DA, Gracely RH (2006) Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia. Arthritis Res Ther 8:224
42. Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160-72 (Pubitemid 20098653)
43. Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Katz RS, Mease P (2010) The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity. Arthritis Care Res 62:600-10
44. Wolfe F, Clauw DJ, Fitzcharles MA et al (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 38:1113-22
45. Woolf CJ (2011) Central sensitization: implications for the diagnosis and treatment of pain. Pain 152:S2-15
46. Yunus MB (2007) Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain. Best Pract Res Clin Rheumatol 21:481-97 (Pubitemid 46972009)
47. Yunus MB (2008) Central sensitivity syndromes: A new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus Illness. Semin Arthr Rheum 37:339-52